Salt solution for colon cleansing
View Patent ↗The field of colonic diagnostic and surgical procedures is hampered by the lack of optimal means available to cleanse the colon. A compromise between convenient, distasteful, solid or low volume, hyperosmotic solutions which cause considerable fluid and electrolyte imbalances in patients and large volume, difficult to consume, iso-osmotic solutions has had to be made heretofore. This invention describes a low volume, hyper-osmotic solution consisting of sulfate salts with and with out polyethylene glycol. Unlike prior art, this composition is useful for the cleansing of the bowel and, in lower volumes, as a laxative, without producing clinically significant changes in bodily function.
1. A composition for inducing purgation of the colon of a patient, the composition comprising a small volume of an aqueous hypertonic solution which comprises an effective amount of one or more salts selected from the group consisting of Na 2 SO 4 , MgSO 4 , and K 2 SO 4 , and an effective amount of PEG, wherein the composition does not produce any clinically significant electrolyte shifts and does not include phosphate.
2. A composition according to claim 1 , wherein the solution comprises an effective amount of Na 2 SO 4 , an effective amount of MgSO 4 , an effective amount of K 2 SO 4 , and an effective amount of PEG.
3. A composition according to claim 2 , wherein the solution comprises between about 2 grams and about 40 grams of Na 2 SO 4 , between about 2 grams and about 20 grams of MgSO 4 , between about 1 gram and about 10 grams of K 2 SO 4 , and between about 0.1 gram and about 50 grams of PEG.
4. A composition for inducing purgation of the colon of a patient according to claim 1 , wherein the solution comprises about 20 grams of Na 2 SO 4 , about 20 grams of MgSO 4 , about 3 grams of K 2 SO 4 , and about 34 grams of PEG.
5. A composition for inducing purgation of the colon of a patient according to claim 4 , wherein the solution has a volume of less than 500 ml.
6. A composition for inducing purgation of the colon of a patient, comprising a small volume of an aqueous hypertonic solution consisting essentially of an effective amount of one or more salts selected from the group consisting of Na 2 SO 4 , MgSO 4 , and K 2 SO 4 , and an effective amount of PEG, wherein the composition does not produce any clinically significant electrolyte shifts and does not include phosphate.
7. A composition for inducing purgation of the colon of a patient according to claim 6 , wherein the solution consists essentially of about 20 grams of Na 2 SO 4 , about 20 grams of MgSO 4 , about 3 grams of K 2 SO 4 , and about 34 grams of PEG in about 330 ml of water.
8. A composition according to claim 1 , wherein the solution is from about 100 ml to about 500 ml in volume.
9. A composition according to claim 1 , wherein the solution comprises an effective amount of two or more salts selected from the group consisting of Na 2 SO 4 , MgSO 4 , and K 2 SO 4 , and an effective amount of PEG.
10. A method for inducing colonic purgation in a patient, comprising the steps of:
(a) orally administering an effective amount of the composition of claim 1 to a patient; and
(b) allowing the administered composition to induce colonic purgation.
11. A method for inducing colonic purgation according to claim 10 , wherein the solution consists essentially of about 20 grams of Na 2 SO 4 , about 20 grams of MgSO 4 , about 3 grams of K 2 SO 4 , and about 34 grams of PEG in about 330 ml of water.
12. A method for inducing colonic purgation in a patient according to claim 10 , wherein the effective amount of the composition is administered in two or more doses within a treatment period.
13. The method of claim 10 , wherein about 100 ml to about 500 ml of the solution is administered to the patient.
14. The method of claim 10 , wherein the solution comprises an effective amount of two or more salts selected from group the consisting of Na 2 SO 4 , MgSO 4 , and K 2 SO 4 , and an effective amount of PEG.
15. A composition for inducing purgation of the colon of a patient, the composition comprising a small volume of an aqueous hypertonic solution comprising an effective amount of Na 2 SO 4 , an effective amount of MgSO 4 , and an effective amount of K 2 SO 4 , wherein the composition does not produce any clinically significant electrolyte shifts and does not include phosphate.
16. A composition according to claim 15 , wherein the solution comprises between about 2 grams and about 40 grams of Na 2 SO 4 , between about 2 grams and about 20 grams of MgSO 4 , and between about 1 gram and about 10 grams of K 2 SO 4 .
17. A composition according to claim 15 , wherein the solution is from about 100 ml to about 500 ml in volume.
18. A composition for inducing purgation of the colon of a patient comprising a small volume of an aqueous hypertonic solution consisting essentially of an effective amount of Na 2 SO 4 , an effective amount of MgSO 4 , and an effective amount of K 2 SO 4 , wherein the composition does not produce any clinically significant electrolyte shifts and does not include phosphate.
19. A method for inducing colonic purgation in a patient, comprising the steps of:
(a) orally administering an effective amount of the composition of claim 18 to a patient; and
(b) allowing the administered composition to induce colonic purgation.
20. A method for inducing colonic purgation in a patient, comprising the steps of:
(a) orally administering an effective amount of the composition of claim 15 to a patient; and
(b) allowing the administered composition to induce colonic purgation.
21. The method of claim 20 , wherein about 100 ml to about 500 ml of the solution is administered to the patient.
22. A method for inducing colonic purgation according to claim 20 , wherein the solution consists essentially of about 20 grams of Na 2 SO 4 , about 20 grams of MgSO 4 , and about 3 grams of K 2 SO 4 .
23. A method for inducing colonic purgation in a patient according to claim 20 , wherein the effective amount of the composition is administered in two or more doses within a treatment period.